This new seven-country study from Venture Planning Group contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of leading market players and start-up firms developing innovative products Research Beam Model: Research Beam Product ID: 174829 0 USD New
2014-2018 World Molecular Diagnostics Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
 
 

2014-2018 World Molecular Diagnostics Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

  • Category : Diagnostic and Biotech
  • Published On : November   2014
  • Pages : 109
  • Publisher : VPGMarketResearch.com
 
 
 

This new seven-country study from Venture Planning Group contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

Business and technological trends in major markets

Five-year test volume and sales forecasts

Market shares of leading competitors

Feature comparison of major analyzers

Strategic profiles of leading market players and start-up firms developing innovative products

Specific product and business opportunities for instrument and consumable suppliers.



Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.



In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.



Geographic Coverage

France

Germany

Italy

Japan

Spain

UK

USA



Worldwide Market Overview

Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment.

Five-year test volume and sales projections by country.



Market Segmentation Analysis

Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.

Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.



A comprehensive analysis of the sequencing market by country and laboratory segment.

Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.



Product/Technology Review

Comparison of leading infectious disease molecular diagnostic analyzers.

Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.



Abbott

Affymetrix

Agilent Technologies

Applied Gene Technologies

Arca/Nuvelo

Beckman Coulter/Danaher

Becton Dickinson

Biokit

BioMerieux

Bio-Rad

Biotest

Caliper

Cepheid

Decode

Diadexus

Eiken

Enzo

Exact Sciences

Fujirebio/Innogenetics

Grifols

Hologic/Gen-Probe

Illumina

Kreatech

Li-Cor Biosciences

Life Technologies/Thermo Fisher

Monogram Biosciences

Myriad Genetics

Nanogen/Elitech

Orchid CellMark

Ortho-Clinical Diagnostics

Proteome Sciences

Qiagen

Roche

Scienion

Sequenom

Shimadzu

Siemens

Sierra Molecular

Takara Bio

Tecan Group

Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations



Specific new product development opportunities with potentially significant market appeal during the next five years.

Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Business planning issues and concerns.


../toc/TOCTOT%20AnalysisoftheWorldMolecularDiagnosticsMarket.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT